KLONDIKE SILVER CORP (KS.CA) Fundamental Analysis & Valuation

TSX-V:KSCA4987222060

Current stock price

0.25 CAD
+0.02 (+6.38%)
Last:

This KS.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. KS.CA Profitability Analysis

1.1 Basic Checks

  • In the past year KS has reported negative net income.
  • KS had a positive operating cash flow in the past year.
  • In the past 5 years KS always reported negative net income.
  • KS had negative operating cash flow in 4 of the past 5 years.
KS.CA Yearly Net Income VS EBIT VS OCF VS FCFKS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

  • With a decent Return On Assets value of -3.72%, KS is doing good in the industry, outperforming 73.96% of the companies in the same industry.
  • The Return On Equity of KS (-5.30%) is better than 72.83% of its industry peers.
Industry RankSector Rank
ROA -3.72%
ROE -5.3%
ROIC N/A
ROA(3y)-5.4%
ROA(5y)-7%
ROE(3y)-7.2%
ROE(5y)-8.69%
ROIC(3y)N/A
ROIC(5y)N/A
KS.CA Yearly ROA, ROE, ROICKS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -5 -10 -15

1.3 Margins

  • KS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KS.CA Yearly Profit, Operating, Gross MarginsKS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025

1

2. KS.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for KS remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, KS has more shares outstanding
  • The debt/assets ratio for KS is higher compared to a year ago.
KS.CA Yearly Shares OutstandingKS.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
KS.CA Yearly Total Debt VS Total AssetsKS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • KS has an Altman-Z score of -1.88. This is a bad value and indicates that KS is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -1.88, KS is not doing good in the industry: 64.53% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.06 indicates that KS is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.06, KS is doing worse than 61.51% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z -1.88
ROIC/WACCN/A
WACCN/A
KS.CA Yearly LT Debt VS Equity VS FCFKS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 0.00 indicates that KS may have some problems paying its short term obligations.
  • The Current ratio of KS (0.00) is worse than 89.56% of its industry peers.
  • KS has a Quick Ratio of 0.00. This is a bad value and indicates that KS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of KS (0.00) is worse than 89.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
KS.CA Yearly Current Assets VS Current LiabilitesKS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

0

3. KS.CA Growth Analysis

3.1 Past

  • KS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. KS.CA Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
KS.CA Price Earnings VS Forward Price EarningsKS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KS.CA Per share dataKS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. KS.CA Dividend Analysis

5.1 Amount

  • KS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

KS.CA Fundamentals: All Metrics, Ratios and Statistics

KLONDIKE SILVER CORP

TSX-V:KS (3/27/2026, 7:00:00 PM)

0.25

+0.02 (+6.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)01-30
Earnings (Next)04-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap6.72M
Revenue(TTM)N/A
Net Income(TTM)-672.60K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF 611.14
P/B 0.53
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFY0.16%
SpS0
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.72%
ROE -5.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.4%
ROA(5y)-7%
ROE(3y)-7.2%
ROE(5y)-8.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.51%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z -1.88
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5553.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-70.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1276.92%
OCF growth 3YN/A
OCF growth 5YN/A

KLONDIKE SILVER CORP / KS.CA Fundamental Analysis FAQ

What is the fundamental rating for KS stock?

ChartMill assigns a fundamental rating of 1 / 10 to KS.CA.


Can you provide the valuation status for KLONDIKE SILVER CORP?

ChartMill assigns a valuation rating of 0 / 10 to KLONDIKE SILVER CORP (KS.CA). This can be considered as Overvalued.


How profitable is KLONDIKE SILVER CORP (KS.CA) stock?

KLONDIKE SILVER CORP (KS.CA) has a profitability rating of 1 / 10.


How financially healthy is KLONDIKE SILVER CORP?

The financial health rating of KLONDIKE SILVER CORP (KS.CA) is 1 / 10.